I-131-CLR1404 Uses, Dosage, Side Effects and more
I-131-CLR1404 is under investigation in clinical trial NCT01495663 (Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned).
| Trade Name | I-131-CLR1404 |
| Generic | NM-404 I-131 |
| NM-404 I-131 Other Names | I-131-CLR1404 |
| Type | |
| Formula | C29H53INO4P |
| Weight | Average: 641.626 Monoisotopic: 641.277345357 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
